Most bought healthcare stocks in Q2 2026
Discover which Healthcare stocks institutional investors added to most aggressively over Q2 2026 versus the prior calendar quarter in our filings. Notable additions at the top of this list include GOSSAMER BIO INC (GOSS), BRISTOL-MYERS SQUIBB CO (BMY), ALLOGENE THERAPEUTICS INC (ALLO), NOVO-NORDISK A/S-SPONS ADR (NVO). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GOSS | GOSSAMER BIO INC | 204,412,710 | $5.7M | 31 | 54 | 43 | 47 | 164 |
| BMY | BRISTOL-MYERS SQUIBB CO | 182,675,849 | $5.4B | 174 | 950 | 932 | 269 | 2384 |
| ALLO | ALLOGENE THERAPEUTICS INC | 131,506,654 | $210.1M | 35 | 96 | 45 | 41 | 200 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 112,479,699 | $3.1B | 215 | 436 | 433 | 185 | 1281 |
| EW | EDWARDS LIFESCIENCES CORP | 101,775,790 | $13.4B | 156 | 441 | 427 | 167 | 1239 |
| MRK | MERCK & CO. INC. | 98,374,123 | $29.2B | 197 | 1540 | 1387 | 279 | 3593 |
| MTD | METTLER-TOLEDO INTERNATIONAL | 89,512,775 | $852.3M | 82 | 235 | 306 | 126 | 762 |
| ALT | ALTIMMUNE INC | 81,208,067 | $243.3M | 61 | 83 | 30 | 28 | 202 |
| CABA | CABALETTA BIO INC | 71,036,228 | $214.2M | 55 | 49 | 20 | 24 | 138 |
| EDIT | EDITAS MEDICINE INC | 68,869,420 | $259.3M | 38 | 74 | 38 | 37 | 205 |
| GILD | GILEAD SCIENCES INC | 68,443,730 | -$3.9B | 141 | 895 | 810 | 268 | 2153 |
| ABBV | ABBVIE INC | 66,323,153 | $52.9B | 264 | 1816 | 1437 | 280 | 3958 |
| RLAY | RELAY THERAPEUTICS INC | 61,500,166 | $2.5B | 50 | 106 | 61 | 45 | 244 |
| VTRS | VIATRIS INC | 59,766,669 | $3.1B | 107 | 340 | 302 | 149 | 958 |
| PFE | PFIZER INC | 58,578,250 | -$12.0B | 151 | 1111 | 1137 | 356 | 2687 |
| JNJ | JOHNSON & JOHNSON | 57,805,153 | $30.7B | 199 | 1967 | 1790 | 307 | 4439 |
| UNH | UNITEDHEALTH GROUP INC | 57,125,784 | $117.8B | 500 | 1224 | 1195 | 274 | 3191 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 55,681,224 | $4.0B | 86 | 258 | 182 | 88 | 639 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 53,589,262 | $426.1M | 50 | 34 | 14 | 19 | 111 |
| CVS | CVS HEALTH CORP | 51,970,351 | $37.2B | 313 | 738 | 693 | 186 | 1967 |
| LXRX | LEXICON PHARMACEUTICALS INC | 43,284,035 | $373.8M | 45 | 35 | 35 | 34 | 145 |
| ABT | ABBOTT LABORATORIES | 42,552,450 | -$12.3B | 187 | 1004 | 1300 | 406 | 2812 |
| AURA | AURA BIOSCIENCES INC | 39,267,880 | $300.4M | 38 | 56 | 23 | 23 | 139 |
| AVTX | AVALO THERAPEUTICS INC | 38,497,323 | $829.8M | 57 | 45 | 13 | 30 | 122 |
| SGMT | SAGIMET BIOSCIENCES INC-A | 37,085,702 | $320.0M | 57 | 35 | 10 | 24 | 119 |
| CCCC | C4 THERAPEUTICS INC | 36,844,616 | $331.7M | 54 | 52 | 25 | 29 | 146 |
| OCGN | OCUGEN INC | 35,746,107 | $21.7M | 46 | 44 | 25 | 35 | 146 |
| BAX | BAXTER INTERNATIONAL INC | 34,683,673 | $3.0B | 101 | 234 | 182 | 98 | 651 |
| NTLA | INTELLIA THERAPEUTICS INC | 34,674,421 | $1.0B | 55 | 133 | 70 | 41 | 310 |
| ABSI | ABSCI CORP | 34,174,791 | $1.4B | 56 | 67 | 47 | 22 | 192 |
| TSHA | TAYSHA GENE THERAPIES INC | 32,854,689 | $833.1M | 44 | 93 | 39 | 32 | 201 |
| AMGN | AMGEN INC | 30,295,560 | $14.1B | 167 | 1195 | 1161 | 256 | 2991 |
| ALRN | AILERON THERAPEUTICS INC | 29,247,997 | $27.4M | 19 | 18 | 3 | 8 | 56 |
| RXRX | RECURSION PHARMACEUTICALS-A | 28,895,463 | $307.9M | 47 | 121 | 95 | 56 | 323 |
| HLN | HALEON PLC-ADR | 28,149,225 | -$21.3M | 85 | 197 | 200 | 90 | 606 |
| COR | CENCORA INC | 28,131,680 | $3.5B | 118 | 398 | 578 | 239 | 1269 |
| STTK | SHATTUCK LABS INC | 27,808,058 | $186.4M | 38 | 35 | 15 | 23 | 98 |
| WRBY | WARBY PARKER INC-CLASS A | 26,830,828 | $1.7B | 65 | 123 | 70 | 70 | 287 |
| AVTR | AVANTOR INC | 26,777,054 | $1.7B | 92 | 178 | 101 | 87 | 430 |
| LUCD | LUCID DIAGNOSTICS INC | 26,044,479 | $25.0M | 25 | 55 | 11 | 15 | 110 |
| INSM | INSMED INC | 25,166,438 | -$7.9B | 117 | 230 | 214 | 147 | 630 |
| IBRX | IMMUNITYBIO INC | 24,881,297 | $442.8M | 60 | 133 | 95 | 64 | 376 |
| OSCR | OSCAR HEALTH INC - CLASS A | 24,824,273 | $3.3B | 116 | 130 | 98 | 62 | 378 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 24,550,567 | $271.2M | 45 | 92 | 49 | 60 | 207 |
| ELAN | ELANCO ANIMAL HEALTH INC | 22,607,157 | $1.1B | 76 | 157 | 190 | 96 | 489 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 22,377,669 | $556.8M | 45 | 72 | 51 | 37 | 213 |
| SANA | SANA BIOTECHNOLOGY INC | 21,890,481 | $175.8M | 35 | 62 | 59 | 32 | 201 |
| OVID | OVID THERAPEUTICS INC | 21,525,259 | $107.2M | 45 | 32 | 27 | 21 | 126 |
| ALHC | ALIGNMENT HEALTHCARE INC | 20,801,420 | $1.6B | 76 | 138 | 74 | 56 | 308 |
| BFLY | BUTTERFLY NETWORK INC | 20,748,842 | $786.4M | 48 | 92 | 54 | 52 | 232 |